GenMont Biotech Incorporation (TPE:3164)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
17.75
+0.05 (0.28%)
At close: Feb 11, 2026

TPE:3164 Balance Sheet

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
74.56110.5155.6133.69169.95274.85
Short-Term Investments
243.86248.13272.71267.26251.78190.28
Cash & Short-Term Investments
318.42358.64328.3400.94421.73465.13
Cash Growth
8.95%9.24%-18.12%-4.93%-9.33%-11.65%
Accounts Receivable
42.8231.638.2350.3654.0142.35
Other Receivables
0.91.731.791.41.054.09
Receivables
43.7233.3340.0251.7655.0646.44
Inventory
73.8277.6788.1255.337.0634.79
Prepaid Expenses
3.854.929.0713.4966.9449.59
Other Current Assets
64.0767.17----
Total Current Assets
503.86541.73465.51521.5580.79595.94
Property, Plant & Equipment
949.051,0371,0601,1131,045922.68
Long-Term Investments
-6.097.3226.5234.6825.33
Other Intangible Assets
2.032.162.260.240.330.25
Long-Term Deferred Tax Assets
48.6642.0439.722.7312.317.76
Other Long-Term Assets
75.4579.8978.2911.5924.860.86
Total Assets
1,5791,7091,6531,6961,6981,613
Accounts Payable
6.016.37.8514.3711.397.39
Accrued Expenses
-----23.98
Short-Term Debt
21.4520.48----
Current Portion of Long-Term Debt
6.9412.242.24---
Current Portion of Leases
1.952.42.361.062.112.04
Current Income Taxes Payable
7.9512.1918.9528.4433.8216.29
Current Unearned Revenue
20.1140.0533.9825.7625.3324.3
Other Current Liabilities
40.0346.4881.0191.1666.5120.96
Total Current Liabilities
104.44140.15146.39160.78139.1794.96
Long-Term Debt
42.6549.2320.11---
Long-Term Leases
33.0134.2633.633.4930.6232.29
Long-Term Deferred Tax Liabilities
3.113.111.591.961.541.39
Other Long-Term Liabilities
2.322.322.372.372.322.32
Total Liabilities
185.54229.07204.06198.59173.65130.95
Common Stock
860.1865.11865.11863.71863.71863.41
Additional Paid-In Capital
351.77353.74377.1375.69375.69386.54
Retained Earnings
87.85128.0289.97117.5154.8790.81
Comprehensive Income & Other
-21.574.9-15.88-5.58-17.83-11.49
Total Common Equity
1,2781,3521,3161,3511,3761,329
Minority Interest
115.34127.9132.82145.89147.95152.6
Shareholders' Equity
1,3941,4801,4491,4971,5241,482
Total Liabilities & Equity
1,5791,7091,6531,6961,6981,613
Total Debt
106118.6158.3134.5532.7334.33
Net Cash (Debt)
212.41240.03270366.4389430.8
Net Cash Growth
22.60%-11.10%-26.31%-5.81%-9.70%-12.76%
Net Cash Per Share
2.452.773.124.234.484.89
Filing Date Shares Outstanding
86.0186.5186.5186.3786.3786.34
Total Common Shares Outstanding
86.0186.5186.5186.3786.3786.34
Working Capital
399.42401.59319.12360.73441.62500.98
Book Value Per Share
14.8615.6315.2215.6515.9415.40
Tangible Book Value
1,2761,3501,3141,3511,3761,329
Tangible Book Value Per Share
14.8415.6015.1915.6415.9315.39
Buildings
888.42923.19886.14877.91168.74168.41
Machinery
480.01489.48481.71419.15234.11230.98
Construction In Progress
0.020.020.0375.24858.62720.57
Source: S&P Global Market Intelligence. Standard template. Financial Sources.